BioTek Instruments recently announced the expansion of its world headquarters in Winooski, Vermont, USA. The company added 8,000 square feet; effectively increasing the size of its Service department by 50% and housing a new applications laboratory. Additionally, existing space will be repurposed to manufacturing; providing space for the company’s new product lines introduced in the coming year and beyond.

Twice the size of the previous lab, BioTek’s new laboratory will be used to stay on the cutting edge of assay development by partnering with major assay developers. The new lab will also be used to develop unique applications for BioTek products and prove their efficacy in real-lab environments. This new facility includes cell culture capability for cell-based assays which represents 75% of the lab’s current activity. Additional space in the Service department includes a dedicated training room to be used for customer visits and to train service engineers from around the world.

Vermont Governor Jim Douglas was at BioTek for the grand opening ceremony and noted, “We will get out of this recession because of successful companies like BioTek. We greatly appreciate their commitment to Vermont and good jobs they provide. My team will continue to do all that we can to support this great company.”

“In a year that has been challenging for individuals and businesses around the world, BioTek has not only survived, but has continued to thrive, and is stronger today than we were a year ago,” Briar Alpert, President and CEO of BioTek Instruments, commented. “This performance is a direct result of our highly skilled, motivated and loyal workforce in combination with a business philosophy that is committed to investing in the people, facilities and tools necessary to meet the challenges of today and to prepare for the challenges of the future.”

BioTek Instruments, Inc., headquartered in Winooski, VT, USA, is a worldwide leader in the design, manufacture, and sale of microplate instrumentation and software. BioTek instrumentation is used to aid in the advancement of life science research, facilitate the drug discovery process and to enable cost-effective quantification of disease relevant molecules in the clinic.